Association for Molecular Pathology Annual Meeting & Expo 2024

The Association for Molecular Pathology (AMP) Annual Meeting & Expo 2024 is the premier global gathering for professionals advancing the science and practice of molecular pathology. This year’s program delivers cutting-edge research, innovative technologies, and real-world clinical applications that are shaping the future of precision medicine. Featuring expert-led sessions, interactive workshops, and an extensive industry expo, the meeting provides a unique opportunity to stay ahead in the rapidly evolving landscape of molecular diagnostics.
What You Will Learn

Breakthroughs in molecular diagnostics, genomics, and biomarker discovery

Clinical applications in oncology, infectious diseases, and inherited disorders

Advances in next-generation sequencing, liquid biopsy, and digital pathology

Best practices for integrating new molecular technologies into clinical care

Updates on regulatory frameworks, reimbursement policies, and quality assurance

Event Details

Event: Association for Molecular Pathology Annual Meeting & Expo 2024

Format: In-person conference with hybrid participation options

Program Highlights: Keynote presentations, scientific sessions, poster discussions, and industry exhibitions

Topics Covered: Emerging technologies, personalized medicine, diagnostic innovations, and bioinformatics solutions

Who Should AttendMolecular pathologists, clinical laboratory directors, medical geneticists, oncologists, infectious disease specialists, researchers, and laboratory professionals. It is also ideal for biotechnology and pharmaceutical professionals, regulatory specialists, and trainees in molecular medicine.
Why AttendThis meeting is a must-attend for anyone seeking to deepen their expertise, explore the latest innovations, and connect with leaders in molecular pathology. Attendees will gain actionable insights, strengthen their professional network, and leave equipped to implement cutting-edge diagnostics and therapeutic strategies in clinical and research settings.
 
+ Topics:
Programs & Schedules

AMP 2024 Workshop Program

AMP On-Site Program Overview

Precision Oncology & CGP

Comprehensive Genomic Profiling (CGP) in Solid & Hematologic Malignancies

Actionable Biomarkers in Early-Stage NSCLC

BRAF Mutations in Metastatic Colorectal Cancer

Gene Fusion Detection Strategies for Oncology

Whole Exome Sequencing in Solid Tumors—Clinical Impact

Radiogenomics: Integrating Molecular and Imaging Data

Tumor Mutational Burden: Validation & Reporting (AMP/CAP/SITC)

Liquid Biopsy, ctDNA & MRD

Pan-Cancer Liquid Biopsy: Technologies & Early Detection

ctDNA Genotyping in NSCLC—Fast, Comprehensive Workflows

MRD Testing in AML: Strategies & Pitfalls

Ultra-Sensitive MRD with Whole-Genome ppmSeq

Cell-Free DNA for MRD in Lymphoid Malignancies

NGS, PCR & Advanced Assays

NGS Implementation Journeys: Hospital & Academic Labs

Rapid NGS for Myeloid/Lymphoid Malignancies

Amplicon-Based NGS: End-to-End CGP Solutions

32-Target Multiplex RT-PCR in 10 Minutes (POC)

Droplet Digital PCR (ddPCR) in Precision Oncology & MRD

Long-Range PCR + Long-Read Sequencing for Hard Genes

qPCR Exosome Workflows for ESR1 & Beyond

Structural Genomics & Spatial Omics

Optical Genome Mapping (OGM) in Leukemia, Lymphoma & Sarcoma

OGM + Long-Read Sequencing for Structural Variants

High-Throughput Spatial Multiomics for Biomarker Discovery

Highly Multiplexed Spatial Transcriptomics in NSCLC

Pharmacogenomics (PGx)

Guideline-Driven PGx Testing (AMP Tier 1–2)

Enterprise-Wide PGx: Practical Integration

Pharmacists’ Roles in Clinical PGx

Global PGx Recommendations (AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar)

Breast Cancer Focus

ESR1 Mutations & ctDNA in Metastatic HR+/HER2- Breast Cancer

PIK3CA, AKT1, PTEN in HR+/HER2- Disease

4-Gene Methylation Panel to Expand PARPi Eligibility

Lab Operations, QA & Compliance

Laboratory Automation: Implementation Essentials

Optimizing Clinical Lab Operations & Testing Consolidation

Assay Development for RNA Targets—Performance & Cost

QC Perfection: Patient-Like Controls & Accuracy

Enterprise CGP/HRD Automation (AVENIO Workflows)

Value of Internalizing FDA-Authorized Tumor Profiling

LDT Compliance in an Uncertain Regulatory Landscape

AMP Lawsuit vs FDA: Oversight of Lab-Developed Tests

Bioinformatics, AI & Data

Clinical Bioinformatician Body of Knowledge

Deep Learning in Precision Medicine

LLMs in Healthcare: Language of Innovation

Standardization Efforts for AI in the Lab

Open-Source Tools for Molecular Pathology

navify & Tertiary Analysis for CGP + HRD Score

Infectious Disease & Public Health

Next-Gen Mycology: Molecular Testing Advances

Infectious Disease Diagnostics—From Gram Stain to NGS

Syndromic Panels for Infectious Diseases

Parasitology in the 21st Century: NAATs for Detection & Surveillance

Molecular at Home & Point-of-Care Testing

Viral Associations in Human Cancer via Genomics

Hematopathology & Myeloid/Neoplasms

CGP Utility in Myeloid Neoplasms

FLT3-ITD & NPM1 MRD by Sensitive NGS

New Molecular Discoveries in B-Cell Neoplasms

Lung Cancer Guidelines & Best Practices

2024 CAP/IASLC/AMP Update: Molecular Testing for TKI Selection in Lung Cancer

Difficult NSCLC Samples: Fast, Cost-Effective Profiling

ctDNA & Ultra-Fast NGS at Diagnosis and Progression

Women’s Health, Equity & Ethics

Disparities in Genetic Testing: Closing the Gap

Role of Gender Identification in Genetic Testing

Biobanking: From Pathology to Repository—Data & Sample Governance

Training, Education & Community

Curated Resources for Training in Molecular Pathology (EdCop)

Technologist Innovation Session

Selected Platform Presentations (Genetics, Informatics, Tech, HemePath, ID, Solid Tumors)

EAC Town Hall: 2024 Activities & Legislative Priorities

Slice Testing: Ordering to Reporting—CAP/NSGC Considerations

Case Studies: Genetics, HemePath, Solid Tumors, Infectious Diseases